Acute Myeloid Leukemia
Conditions
Interventions
None listed
Sponsors
Kyushu University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients aged 16 and older diagnosed with AML who, as of the date of approval for this study, participated in the 'Kyushu Clinical Sample Network (KCNET)' study and who have also consented to the secondary use of their data.
Exclusion criteria
Exclusion criteria: (1) If the principal investigator, research director, or attending physician determines that enrollment in the study is inappropriate. (2) If the collection of samples is deemed unsafe for the patient or donor. (3) If, for any reason, it is difficult to collect samples. (4) If a lack of research funding makes it difficult to maintain the 'Kyushu Clinical Sample Network (KCNET)' study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Correlation between MRD Trends before, during, and after Treatment and Prognosis in AML | — |
Secondary
| Measure | Time frame |
|---|---|
| Correlation between Existing Methods for MRD Detection (such as the LAIP Method in Flow Cytometry, Chimeric Gene PCR, WT1, etc.) and the Flow Cytometry Method Examined in this Study, and Comparison of the Sensitivity of Each Method | — |
Countries
Japan
Contacts
Public ContactTeppei Sakoda
Kyushu University Hospital Hematology, Oncology, and Cardiovascular Medicine
Outcome results
None listed